Navigation Links
FMC Corporation Announces Exclusive Global Development and Supply Agreements for Chr. Hansen Biological Products
Date:8/23/2011

PHILADELPHIA, Aug. 23, 2011 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today its Agricultural Products Group has entered into two exclusive agreements covering global development and supply of Chr. Hansen biological products for agricultural and ornamental markets.  FMC will begin commercialization this year of Chr. Hansen's Nemix bacillus product in Brazil and start development for new biological standalone and combination products in the Americas and key agricultural markets.

Under the agreements, FMC will access Chr. Hansen's large library of existing bacillus products to evaluate and develop other biological products for use in agriculture as nematicides and plant health promoters.  Chr. Hansen will supply biological materials for products that FMC commercializes under the agreements.  Terms of the agreements were not disclosed.

“The Chr. Hansen biological products are complementary to FMC’s portfolio of crop protection products and offer additional solutions to growers in FMC’s focus markets,” said Milton Steele, president, FMC Agricultural Products Group. “This relationship opens exciting new opportunities for FMC’s Agricultural Products Group and is clearly aligned with our growth strategy by expanding in adjacent spaces to chemical crop protection markets.”

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. All solutions are based on strong research and development competencies and significant technology investments. The company enjoys market leadership in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors Division. There are more than 2,300 dedicated employees in over 30 countries.

FMC Corporation is a diversified chemical company serving agricultural, industrial and consumer markets globally for more than a century with innovative solutions, applications and quality products.  The company employs approximately 5,000 people throughout the world.  The company operates its businesses in three segments: Agricultural Products, Specialty Chemicals and Industrial Chemicals.

Safe Harbor Statement under the Private Securities Act of 1995: Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning specific factors described in FMC Corporation's 2010 Form 10-K and other SEC filings.  Such information contained herein represents management's best judgment as of the date hereof based on information currently available.  FMC Corporation does not intend to update this information and disclaims any legal obligation to the contrary.  Historical information is not necessarily indicative of future performance.


'/>"/>
SOURCE FMC Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. TriLink BioTechnologies, Inc. Announces License Agreement with Lucigen Corporation
2. United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
3. United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011
4. Neogen Corporation Announces Year-End Results Conference Call
5. Celladon Corporation Announces Publication of Advanced Heart Failure Clinical Trial Results With MYDICAR® Enzyme Replacement Therapy in the Journal Circulation
6. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
7. Fox Chase Cancer Center Signs Agreement with Life Technologies Corporation
8. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011
9. China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results
10. Biomerix Corporation Reaches European Distribution Agreement with Cellon S.A.
11. Designed by Kids, Built by Volunteers: Roche, New Jersey Community Development Corporation, and KaBOOM! Build New Playground in Just One Day for Paterson Public School Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... Equicare Health Inc ., the leading supplier of comprehensive ... the top 100 companies in the 2016 Global Digital ... top digital health companies across the globe.   ... continually upgrading our product with the ongoing digital shift ... Len Grenier , CEO of Equicare Health, "It,s ...
(Date:11/30/2016)... 2016   Merck , ein führendes ... einer Reihe von Vereinbarungen mit Evotec AG ... Screeningleistungen für Mercks Palette genetischer Reagenzien wie ... diese Bibliotheken in Kombination mit Evotecs Expertise ... zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
(Date:11/30/2016)... ... , ... SSCI, the established leader in small-molecule cocrystal technology and development, will ... on pharmaceutical cocrystals as drug substance . The Lunch and Learn will ... follows the successful November 15th event that took place in Burlingame, CA. Eyal H. ...
(Date:11/30/2016)... ... November 30, 2016 , ... On 28 November 2016, the International Union ... nihonium (Nh), moscovium (Mc), tennessine (Ts), and oganesson (Og), respectively for element 113, ... earlier proposed by the discoverers have been approved by the IUPAC Bureau. The IUPAC ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market by Authentication ... (Hardware and Software), Function (Contact and Non-contact), Application, and Region - Global ... from USD 10.74 Billion in 2015 to reach USD 32.73 Billion by ... Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
Breaking Biology News(10 mins):